# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA750554 | F | In vivo agonist efficacy as the maximal lysosomal myeloperoxidase (MPO) release in PMNL assay | 5 | organism-based format | Scientific Literature | |||
2. | ALA750555 | F | In vivo agonist efficacy was determined as the maximal lysosomal myeloperoxidase (MPO) release in PMNL assay. | 11 | organism-based format | Scientific Literature | |||
3. | ALA750556 | F | In vivo potency as the maximal lysosomal myeloperoxidase (MPO) release in PMNL assay | 5 | organism-based format | Scientific Literature | |||
4. | ALA750557 | F | In vivo potency was determined as the maximal lysosomal myeloperoxidase (MPO) release in PMNL assay. | 11 | organism-based format | Scientific Literature | |||
5. | ALA750770 | F | Compound was evaluated for the inhibition of serum-opsonized zymosan stimulated myeloperoxidase release from human neutrophil | Homo sapiens | 1 | assay format | Scientific Literature | ||
6. | ALA750777 | F | Tested in vivo for the ability to inhibit myeloperoxidase (MPO) activity in the colon of the TNB/ethanol-induced chronic colitis rats at the dosage of 100 mg/kg/day | Rattus norvegicus | 6 | organism-based format | Scientific Literature | ||
7. | ALA750778 | F | Tested in vivo for the ability to inhibit myeloperoxidase (MPO) activity in the colon of the TNB/ethanol-induced chronic colitis rats at the dosage of 500 mg/kg/day | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
8. | ALA840669 | F | Ability to inhibit C5a-induced release of azurophilic granular constituent myeloperoxidase (MPO) from intact neutrophils | 1 | assay format | Scientific Literature | |||
9. | ALA841524 | F | Compound was tested for the induction of nonspecific myeloperoxidase (MPO) release | 5 | assay format | Scientific Literature | |||
10. | ALA931190 | B | Inhibition of chlorinating activity of recombinant myeloperoxidase by taurine assay | 13 | tissue-based format | Scientific Literature | |||
11. | ALA932250 | B | Inhibition of chlorinating activity of recombinant myeloperoxidase at 0.5 uM by taurine assay | 12 | tissue-based format | Scientific Literature | |||
12. | ALA932251 | B | Inhibition of chlorinating activity of recombinant myeloperoxidase at 1 uM by taurine assay | 12 | tissue-based format | Scientific Literature | |||
13. | ALA932252 | B | Inhibition of chlorinating activity of recombinant myeloperoxidase at 2 uM by taurine assay | 12 | tissue-based format | Scientific Literature | |||
14. | ALA932253 | B | Inhibition of chlorinating activity of recombinant myeloperoxidase at 4 uM by taurine assay | 12 | tissue-based format | Scientific Literature | |||
15. | ALA1027367 | B | Inhibition of MPO activity in TNF-alpha-stimulated human HL60 cells measured enzyme activity per 10'6 cells by spectrophotometrically | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
16. | ALA1027368 | B | Inhibition of MPO activity in TNF-alpha-stimulated human HL60 cells measured enzyme activity per 10'6 cells at 10 uM by spectrophotometrically | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
17. | ALA1027369 | B | Inhibition of MPO activity in TNF-alpha-stimulated human HL60 cells measured enzyme activity per 10'6 cells at 50 uM by spectrophotometrically | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
18. | ALA1287076 | B | Inhibition of human myeloperoxidase at 10 uM | Homo sapiens | 1 | single protein format | Scientific Literature | ||
19. | ALA1640944 | B | Inhibition of recombinant MPO assessed as rate of electron donation to MPO redox intermediate compound I by sequential mixing stopped flow spectroscopy | 2 | single protein format | Scientific Literature | |||
20. | ALA1640945 | B | Inhibition of recombinant MPO mediated taurine chlorination by microplate reader method | 24 | tissue-based format | Scientific Literature |